● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
● The earnings growth currently anticipated by analysts for the coming years is particularly strong.
● Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
● Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
● Thanks to a sound financial situation, the firm has significant leeway for investment.
● The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
● Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
● With an expected P/E ratio at 575.33 and 266.84 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
● The company's "enterprise value to sales" ratio is among the highest in the world.
● The company appears highly valued given the size of its balance sheet.
● The company is highly valued given the cash flows generated by its activity.
● The company is not the most generous with respect to shareholders' compensation.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the past year, analysts have significantly revised downwards their profit estimates.
● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
● The overall consensus opinion of analysts has deteriorated sharply over the past four months.
● Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.